↓ Skip to main content

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Overview of attention for article published in The Lancet, May 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Citations

dimensions_citation
1249 Dimensions

Readers on

mendeley
1604 Mendeley
Title
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Published in
The Lancet, May 2020
DOI 10.1016/s0140-6736(20)31042-4
Pubmed ID
Authors

Ivan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso, Raymond Liu, Tom Wai-Hin Chung, Man-Yee Chu, Yuk-Yung Ng, Jenny Lo, Jacky Chan, Anthony Raymond Tam, Hoi-Ping Shum, Veronica Chan, Alan Ka-Lun Wu, Kit-Man Sin, Wai-Shing Leung, Wai-Lam Law, David Christopher Lung, Simon Sin, Pauline Yeung, Cyril Chik-Yan Yip, Ricky Ruiqi Zhang, Agnes Yim-Fong Fung, Erica Yuen-Wing Yan, Kit-Hang Leung, Jonathan Daniel Ip, Allen Wing-Ho Chu, Wan-Mui Chan, Anthony Chin-Ki Ng, Rodney Lee, Kitty Fung, Alwin Yeung, Tak-Chiu Wu, Johnny Wai-Man Chan, Wing-Wah Yan, Wai-Ming Chan, Jasper Fuk-Woo Chan, Albert Kwok-Wai Lie, Owen Tak-Yin Tsang, Vincent Chi-Chung Cheng, Tak-Lun Que, Chak-Sing Lau, Kwok-Hung Chan, Kelvin Kai-Wang To, Kwok-Yung Yuen

X Demographics

X Demographics

The data shown below were collected from the profiles of 1,298 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1,604 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1604 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 198 12%
Researcher 184 11%
Student > Master 145 9%
Student > Ph. D. Student 128 8%
Other 117 7%
Other 328 20%
Unknown 504 31%
Readers by discipline Count As %
Medicine and Dentistry 383 24%
Biochemistry, Genetics and Molecular Biology 137 9%
Pharmacology, Toxicology and Pharmaceutical Science 132 8%
Immunology and Microbiology 60 4%
Agricultural and Biological Sciences 53 3%
Other 252 16%
Unknown 587 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2118. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 March 2024.
All research outputs
#4,189
of 25,587,485 outputs
Outputs from The Lancet
#185
of 42,837 outputs
Outputs of similar age
#299
of 418,442 outputs
Outputs of similar age from The Lancet
#15
of 380 outputs
Altmetric has tracked 25,587,485 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 42,837 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 68.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 418,442 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 380 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.